the Discount Israel Corporation, an investment bank, and Advent Venture Partners, a premier VC firm from Boston. It was led by Ed Mlavsky, the longtime director of the BIRD Foundation, and Yossi Sela.
Clint Harris, a partner at Advent, said he knew something was different about Israel on his first trip. In the taxicab on the way from the airport to his Tel Aviv hotel, the driver asked him why he was visiting Israel. Harris replied that he was there to get a sense of the venture capital industry. The driver then proceeded to give Harris a briefing on the state of VC in Israel.
The Advent-sponsored fund would be called Gemini Israel Funds. One of its first investments was in November 1993, when it allocated $1 million to Ornet Data Communications. This investment, as well as the managerial help, was just what Ornet needed to succeed. Recognizing the company management’s lack of business experience, Mlavsky and Sela helped recruit Meir Burstin to serve as chairman of the board for the new company. Burstin was an old hand in the high-tech entrepreneurial world, having founded and led Tekem, one of Israel’s first software companies, and then served as president of Tadiran, one of Israel’s big defense-technology companies. Burstin brought instant credibility and experience to Ornet.
When the company was teetering on the brink of closing down after wasting the first big financing round, Yossi Sela from Gemini took over as interim CEO of the company and commuted from Ramat Hasharon to Karmiel, a two-hour drive, four days a week. “It took six months of single-minded determination,” Sela recalled, “from both Gemini and the Ornet founding team, to sell the company and keep the management team from splintering—not to mention more hours driving from Ramat Hasharon to Karmiel than I’d like to remember—but we did it.”14
The other piece that was critical to the company’s success was Gemini’s ability to bring Walden Venture Capital in as an investor. Walden, an established firm in Silicon Valley, had experience in the kind of technology Ornet had developed. Returning over three times its investment in about two years made Ornet Gemini’s first success story.
The ten Yozma funds created between 1992 and 1997 raised just over $200 million with the help of government funding. Those funds were bought out or privatized within five years, and today they manage nearly $3 billion of capital and support hundreds of new Israeli companies. The results were clear. As Erel Margalit put it, “Venture capital was the match that sparked the fire.”15
Several of the Yozma funds had high-profile successes early on, with investments in companies such as ESC Medical, which designed and built light-based medical solutions like lasers; Galileo, a high-end semiconductor firm; Commontouch, an enterprise e-mail and messaging provider; and Jacada, which builds online work spaces for customer- service employees at leading companies.
Along the way, others jumped into the venture capital world—even without the government’s Yozma backing. Jon Medved just missed the Yozma financing. Years after he sold the company he and his father had built, he heard that there was a $5 million Yozma allotment available to invest in very-early-stage companies. Known as seed funds, these investments tend to be considered the riskiest, so Yozma offered a one-to-one match: investors had to bring $2.5 million to the table to get the government’s $2.5 million.
Medved went to Yigal Erlich with investors ready to write checks and asked for the grant. Unfortunately, it was too late. But it didn’t matter. The Yozma program was generating the buzz in the U.S. venture community to overcome investors’ reticence about doing business in Israel. “Israel had excited investors enough that we were able to bring in the $2.5 million and start Israel Seed Partners in 1994,” even without the government’s matching grant, Medved said. The fund would quickly grow to $6 million, and Israel Seed would go on to raise $40 million in 1999 and $200 million in 2000.
According to the Israel Venture Association, there are now forty-five Israeli venture capital funds. Ed Mlavsky said that over the period from 1992 to early 2009, there have been as many as 240 VCs in Israel, defined as companies both foreign and domestic investing in Israeli start-ups.
Soon other governments around the world were taking notice of Yozma’s success. Chief scientist Erlich got calls from foreign governments, including Japan, South Korea, Canada, Ireland, Australia, New Zealand, Singapore, and Russia, all wanting to come to Israel and meet the founders of Yozma.
In December 2008, Ireland launched a 500 million “innovation fund” designed to attract cofinancing from foreign venture capitalists. “The Irish state—ironically for a country that didn’t have diplomatic relations with Israel for the first 40 years of its existence—has copied the Jewish state,” wrote Irish economist David McWilliams.
Like Yozma, the Irish innovation fund lures foreign VCs to Ireland through a series of state-backed venture capital funds that partner up with private-sector funds.
McWilliams said, “The big idea is not to attract only U.S. capital and commercial know-how, but to suck in
